Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTrustpilot Regulatory News (TRST)

Share Price Information for Trustpilot (TRST)

Share Price is delayed by 15 minutes
Get Live Data
254.00    4.20 (1.68%)
Bid:
256.20
Ask:
256.80
Spread: 0.60 (0.234%)
Market Cap: £982.28m
TRST Live PriceLast checked at - London Stock Exchange

Intraday Trustpilot Share Chart

Stabilisation Notice

7 Sep 2021 17:52

RNS Number : 0371L
Morgan Stanley & Co. Int'l plc
07 September 2021
 

2021/09/07

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

Trustpilot Group plc

Post-Stabilisation Notice

Morgan Stanley & Co. International plc (contact: James Cresswell; telephone: +44 (0)20 7677 0981) hereby gives notice that it undertook stabilisation (within the meaning of Article 3(2)(d) of Regulation (EU) 596/2014, including as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018)) in relation to the offer of the following securities, as set out below.

Issuer

Trustpilot Group plc

ISIN

GB00BNK9TP58

Description

Ordinary registered shares ("ORDs" or "Ordinary Shares") of the Issuer

Stabilisation Manager(s)

Morgan Stanley & Co. International plc, 25 Cabot Square, Canary Wharf, London E14 4QA

Offer Price

265 pence per Offer Share

Offer Size

178,596,461 Ordinary Shares (excluding the over-allotment option)

Stabilisation Started

2021/03/23

Stabilisation Last Occurred

2021/04/06

Price Range of Stabilisation Trades

GBP 2.5000 - GBP 2.6500

Stabilisation Trading Venue

London Stock Exchange multilateral trading facility MTF (XLOM); London Stock Exchange (XLON); Turquoise Lit Auctions (TRQA); Turquoise (TRQX); Turquoise Plato (TRQM); CBOE Europe - CXE Dark Order Book (CHID); POSIT Dark (XPOS); Morgan Stanley and Co. International PLC - Systematic Internaliser (MSSI); Morgan Stanley and Co. International Plc (MSIP)

 

 

For each of the dates during which stabilisation transactions were carried out, the price range was as follows:

 

 

 

 

Date

Lowest Price

(GBP)

Highest Price

(GBP)

Trading Venue

2021/03/23

2.6500

2.6500

XLOM

2021/03/24

2.5000

2.6500

XLOM, MSIP, MSSI

2021/03/25

2.5560

2.6500

XLOM, MSIP

2021/03/26

2.6200

2.6500

XLON

2021/03/29

2.5808

2.6500

XLON, XPOS, TRQX, TRQM

2021/03/30

2.6000

2.6500

XLON, XPOS, TRQX, TRQA

2021/03/31

2.6270

2.6500

XLON, XPOS, TRQX, TRQM, CHID, MSIP

2021/04/01

2.6340

2.6500

XLON, TRQX

2021/04/06

2.6500

2.6500

XLON

 

For details of the options granted by certain of the selling shareholders to the underwriters (so called Greenshoe Option) please refer to the notice dated 16 April 2021: https://www.investegate.co.uk/trustpilot-group-plc/rns/exercise-of-over-allotment-option/202104161739337979V/ 

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within Article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, the UK before the publication of a prospectus in relation to the securities which has been approved by the competent authority in the UK in accordance with Regulation (EU) 2017/1129 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018 (the "UK Prospectus Regulation"), this announcement and the offer are only addressed to and directed at persons in the UK who are qualified investors within the meaning of the UK Prospectus Regulation (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in the UK.

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with Regulation (EU) 2017/1129 (the "EEA Prospectus Regulation") (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the EEA Prospectus Regulation), this announcement and the offer are only addressed to and directed at persons in Member State who are qualified investors within the meaning of the EEA Prospectus Regulation (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State.

This announcement is not an offer of securities for sale into the United States. The securities referred to above have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There has not been and will not be a public offer of the securities in the United States.

END.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STALRMFTMTIMBLB
Date   Source Headline
11th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20269:00 amRNS-RShazadi Stinton appointed as Chief Trust Officer
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 202612:27 pmRNSTotal Voting Rights
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
19th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 20267:00 amRNSTransaction in Own Shares
16th Feb 20267:00 amRNSTransaction in Own Shares
13th Feb 20267:00 amRNSTransaction in Own Shares
12th Feb 20267:00 amRNSTransaction in Own Shares
11th Feb 20264:34 pmRNSHolding(s) in Company
11th Feb 202612:26 pmRNSDirector/PDMR Shareholding - Replacement
11th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20267:05 amRNSTransaction in Own Shares
3rd Feb 20267:05 amRNSTransaction in Own Shares
2nd Feb 20267:05 amRNSTransaction in Own Shares
30th Jan 20262:22 pmRNSTotal Voting Rights
30th Jan 20267:05 amRNSTransaction in Own Shares
29th Jan 20267:05 amRNSTransaction in Own Shares
28th Jan 20267:05 amRNSTransaction in Own Shares
27th Jan 20267:05 amRNSTransaction in Own Shares
26th Jan 20267:05 amRNSTransaction in Own Shares
23rd Jan 20267:05 amRNSTransaction in Own Shares
22nd Jan 20267:05 amRNSTransaction in Own Shares
21st Jan 20267:05 amRNSTransaction in Own Shares
20th Jan 20267:05 amRNSTransaction in Own Shares
14th Jan 202611:11 amRNSHolding(s) in Company
13th Jan 20262:05 pmRNSHolding(s) in Company
13th Jan 20267:49 amRNSExtension of Share Buyback Programme
13th Jan 20267:00 amRNSStrong FY 25 performance: 18% cc bookings growth
8th Jan 20267:05 amRNSTransaction in Own Shares
7th Jan 20267:05 amRNSTransaction in Own Shares
6th Jan 20267:05 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.